KIMBERLY RIDDLESPURGER: Open Payments
NPI 1194239079 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,280 in 122 payments from 10 companies in 2025. Trend: 2023 $404 · 2024 $309 · 2025 $2,280
Food & beverage: $2,280
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 21 | $388 |
| Axsome Therapeutics, Inc. | 16 | $364 |
| Neurocrine BioSciences, Inc. | 28 | $329 |
| Otsuka America Pharmaceutical, Inc. | 7 | $329 |
| E.R. Squibb & Sons, L.L.C. | 10 | $288 |
| Teva Pharmaceuticals USA, Inc. | 20 | $235 |
| Lundbeck LLC | 9 | $146 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $71 |
| Alkermes, Inc. | 4 | $69 |
| ABBVIE INC. | 3 | $60 |
Products named: Auvelity, INGREZZA, REXULTI, COBENFY, INVEGA SUSTENNA, SPRAVATO, ABILIFY MAINTENA, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
